Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Regular | Regular |
| Fund house | Tata | Axis |
| AUM | ₹210 Cr | ₹744 Cr |
| NAV | ₹15.6794 | ₹21.0407 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 4.6 years |
| Expense ratio | 1.1% | 1.1% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 70.00 |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| 1 month | — | +6.68% |
| 3 months | — | −2.38% |
| 6 months | — | +2.09% |
| YTD | — | +3.25% |
| 1 year | — | +2.44% |
| 3 years (CAGR) | — | +13.82% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +17.36% |
Risk
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Volatility | — | 18.7% |
| Downside volatility | — | 12.7% |
| Sharpe | — | 0.39 |
| Sortino | — | 0.58 |
| Calmar | — | 0.67 |
| Return / risk | — | 0.74 |
| Deepest fall | — | −20.54% |
| Days to recover | — | 248 |
| Below its high | — | −3.36% |
Against benchmark
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Best 1-year | — | +64.12% |
| Middle 1-year | — | +14.67% |
| Worst 1-year | — | −6.63% |
| 1-year periods with a loss | — | 8.9% |
| Middle 3-year | — | +23.03% |
| Positive months | — | 66.7% |
| Best day | — | +4.98% |
| Worst day | — | −7.72% |
| Worst 5% day | — | −1.97% |
| Positive days | — | 55.1% |
| NAVs a year | — | 251 |
SIP of ₹10,000 a month
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | +8.62% |
| 1-year XIRR | — | +7.38% |
Holdings overlap i
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Tata Nifty MidSmall Healthcare Index Fund Regular · filing Oct 2026 | — | 14% |
| Axis Nifty Midcap 50 Index Fund Regular · filing Oct 2026 | 14% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata Nifty MidSmall Healthcare Index Fund and Axis Nifty Midcap 50 Index Fund
Overlap
14.0%
smaller weight of each shared stock, added up
Stocks in common
6
of 30 and 50
Weight in common
44% · 14%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | Counts toward overlap |
|---|---|---|---|
| Laurus Labs Limited | 14.12% | 4.49% | 4.49% |
| Lupin Limited | 7.36% | 2.34% | 2.34% |
| Aurobindo Pharma Limited | 7.00% | 2.23% | 2.23% |
| Fortis Healthcare Limited | 6.03% | 1.92% | 1.92% |
| Glenmark Pharmaceuticals Limited | 5.22% | 1.66% | 1.66% |
| Mankind Pharma Limited | 4.26% | 1.35% | 1.35% |
| 6 stocks | 44.0% | 14.0% | 14.0% |
Only in Tata Nifty MidSmall Healthcare Index Fund (24)
| Alkem Laboratories Limited | 4.65% |
| IPCA Laboratories Limited | 4.04% |
| Gland Pharma Limited | 3.72% |
| Biocon Limited | 3.70% |
| Sai Life Sciences Limited | 3.25% |
| Acutaas Chemicals Limited | 3.13% |
| Krishna Institute Of Medical Sciences Limited | 2.82% |
| Aster DM Quality Care Limited | 2.74% |
| Neuland Laboratories Limited | 2.56% |
| Ajanta Pharma Limited | 2.41% |
| Wockhardt Limited | 2.37% |
| Dr. Lal Path Labs Limited | 2.24% |
| Piramal Pharma Limited | 2.24% |
| Abbott India Limited | 2.01% |
| Granules India Limited | 1.87% |
| Onesource Specialty Pharma Limited | 1.85% |
| Narayana Hrudayalaya Limited | 1.79% |
| Global Health Limited | 1.70% |
| Glaxosmithkline Pharmaceuticals Limited | 1.56% |
| Anthem Biosciences Limited | 1.35% |
| Natco Pharma Limited | 1.16% |
| Syngene International Limited | 1.15% |
| Cohance Lifesciences Limited | 1.09% |
| Poly Medicure Limited | 0.83% |
Only in Axis Nifty Midcap 50 Index Fund (44)
| The Federal Bank Limited | 4.02% |
| Multi Commodity Exchange of India Limited | 3.90% |
| The Indian Hotels Company Limited | 3.42% |
| One 97 Communications Limited | 3.37% |
| Hero MotoCorp Limited | 3.22% |
| Persistent Systems Limited | 3.15% |
| Bharat Heavy Electricals Limited | 2.71% |
| IndusInd Bank Limited | 2.65% |
| AU Small Finance Bank Limited | 2.41% |
| Ge Vernova T&D India Limited | 2.39% |
| Indus Towers Limited | 2.34% |
| Bharat Forge Limited | 2.29% |
| IDFC First Bank Limited | 2.29% |
| FSN E-Commerce Ventures Limited | 2.29% |
| Info Edge (India) Limited | 2.21% |
| Dixon Technologies (India) Limited | 2.20% |
| Marico Limited | 2.03% |
| Ashok Leyland Limited | 1.99% |
| Suzlon Energy Limited | 1.98% |
| APL Apollo Tubes Limited | 1.89% |
| United Spirits Limited | 1.89% |
| ICICI Lombard General Insurance Company Limited | 1.85% |
| Phoenix Mills Limited | 1.75% |
| REC Limited | 1.71% |
| PB Fintech Limited | 1.70% |
and 19 smaller holdings (24.4% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Large companies | — | 5.1% |
| Mid companies | 68.2% | 95.0% |
| Small companies | 32.0% | — |
| Top 10 holdings | 60.1% | 33.3% |
| Largest sector | Pharmaceuticals & Biotechnology 81% | Banks 13% |